Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › 2,4-diaminopyrimidine derivates as PTK2-inhibitors for the treatment of abnormal cell growth

2,4-diaminopyrimidine derivates as PTK2-inhibitors for the treatment of abnormal cell growth

US Patent 8377943 · Granted Feb 19, 2013

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Substituted 1H-pyrazolo[4,3-c]pyridines and derivatives as EGFR inhibitors2024
Annulated 2-amino-3-cyano thiophenes and derivatives for the treatment of cancer2024
Benzylamino substituted pyridopyrimidinones and derivatives as SOS1 inhibitors2023
Crystalline salts of a B-RAF kinase inhibitor2023
Crystalline salts of a B-RAF kinase inhibitor2022
Medical use of compound III2021
Benzylamino substituted pyridopyrimidinones and derivatives as SOS1 inhibitors2020
Pyrimidine compounds containing seven-membered fused ring systems2017
Pyrimidine compounds containing seven-membered fused ring systems2017
Chemical compounds2014
Azaindolylphenyl sulfonamides as serine/threonine kinase inhibitors2014
Substituted pyrimidines for the treatment of diseases such as cancer2014